Free Trial

SkinBioTherapeutics (SBTX) Competitors

SkinBioTherapeutics logo
GBX 16 -0.25 (-1.54%)
(As of 11:29 AM ET)

SBTX vs. CIR, SCLP, TILS, VSN, FUM, MPH, ORPH, REDX, ETX, and TRX

Should you be buying SkinBioTherapeutics stock or one of its competitors? The main competitors of SkinBioTherapeutics include Circassia Group (CIR), Scancell (SCLP), Tiziana Life Sciences (TILS), Verseon (VSN), Futura Medical (FUM), Mereo BioPharma Group plc (MPH.L) (MPH), Open Orphan (ORPH), Redx Pharma (REDX), e-therapeutics (ETX), and Tissue Regenix Group (TRX). These companies are all part of the "biotechnology" industry.

SkinBioTherapeutics vs.

Circassia Group (LON:CIR) and SkinBioTherapeutics (LON:SBTX) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, earnings, valuation, media sentiment, risk, analyst recommendations, profitability, institutional ownership and community ranking.

Circassia Group's return on equity of 0.00% beat SkinBioTherapeutics' return on equity.

Company Net Margins Return on Equity Return on Assets
Circassia GroupN/A N/A N/A
SkinBioTherapeutics N/A -118.63%-61.18%

In the previous week, SkinBioTherapeutics had 1 more articles in the media than Circassia Group. MarketBeat recorded 1 mentions for SkinBioTherapeutics and 0 mentions for Circassia Group. SkinBioTherapeutics' average media sentiment score of 0.68 beat Circassia Group's score of 0.00 indicating that SkinBioTherapeutics is being referred to more favorably in the news media.

Company Overall Sentiment
Circassia Group Neutral
SkinBioTherapeutics Positive

Circassia Group received 78 more outperform votes than SkinBioTherapeutics when rated by MarketBeat users. Likewise, 71.43% of users gave Circassia Group an outperform vote while only 60.26% of users gave SkinBioTherapeutics an outperform vote.

CompanyUnderperformOutperform
Circassia GroupOutperform Votes
125
71.43%
Underperform Votes
50
28.57%
SkinBioTherapeuticsOutperform Votes
47
60.26%
Underperform Votes
31
39.74%

Circassia Group has higher revenue and earnings than SkinBioTherapeutics. SkinBioTherapeutics is trading at a lower price-to-earnings ratio than Circassia Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Circassia Group£27.90M5.11N/A£0.013,400.00
SkinBioTherapeutics£21.95K1,648.11-£2.88M-£0.02-800.00

16.6% of SkinBioTherapeutics shares are held by institutional investors. 20.4% of SkinBioTherapeutics shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Summary

Circassia Group beats SkinBioTherapeutics on 7 of the 12 factors compared between the two stocks.

Get SkinBioTherapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for SBTX and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SBTX vs. The Competition

MetricSkinBioTherapeuticsBiotechnology IndustryMedical SectorLON Exchange
Market Cap£36.17M£164.83M£5.06B£1.39B
Dividend YieldN/A3.25%4.97%11.73%
P/E Ratio-800.00329.4789.021,551.34
Price / Sales1,648.1114,958.631,207.28209,137.85
Price / Cash9.0011.6739.1732.93
Price / Book8.007.116.082.80
Net Income-£2.88M-£18.52M£119.07M£152.70M
7 Day Performance16.79%-0.33%-1.84%-0.51%
1 Month Performance8.47%8.00%-3.65%7.08%
1 Year Performance-15.79%25.99%31.62%91.78%

SkinBioTherapeutics Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SBTX
SkinBioTherapeutics
N/AGBX 16
-1.5%
N/A-21.4%£36.17M£21,949.00-800.0011
CIR
Circassia Group
N/AGBX 34
-6.8%
N/A+0.0%£142.66M£27.90M3,400.00111Gap Down
SCLP
Scancell
N/AGBX 14.11
-5.9%
N/A+12.4%£131.17M£5.27M-1,500.0051Gap Down
TILS
Tiziana Life Sciences
N/AGBX 58.50
+8.3%
N/A+0.0%£113.85M£-3,595,000.00-3.5911Positive News
VSN
Verseon
N/AGBX 74
+2.1%
N/A+0.0%£112.24MN/A-5.17N/AGap Up
FUM
Futura Medical
N/AGBX 33.16
-0.4%
N/A+10.4%£100.27M£8.40M-3,298.8012News Coverage
MPH
Mereo BioPharma Group plc (MPH.L)
N/AGBX 26.50
-1.9%
N/A+0.0%£89.76MN/A-0.2150Gap Down
ORPH
Open Orphan
N/AGBX 10
+5.3%
N/A+0.0%£67.09M£34.71M-25.30179
REDX
Redx Pharma
N/AGBX 15
+31.6%
N/A-40.0%£58.35M£4.20M-150.00101News Coverage
Gap Up
High Trading Volume
ETX
e-therapeutics
N/AGBX 9
-6.7%
N/A-13.9%£52.59M£295,000.00-450.0035High Trading Volume
TRX
Tissue Regenix Group
N/AGBX 56
-5.1%
N/A+4.7%£39.89M£31.80M-5,926.70120

Related Companies and Tools


This page (LON:SBTX) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners